Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Natural Vascular Scaffolding (NVS) Therapy for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Proximal Popliteal Artery (PPA)

NCT04188262 is registered in ClinicalTrials.gov with Alucent Biomedical as lead sponsor.

NCT NCT04188262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04188262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Natural Vascular Scaffolding (NVS) Therapy for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Proximal Popliteal Artery (PPA)
Lead sponsor
Alucent Biomedical
Phase
Phase 1
Overall status
Completed
Start date
May 22, 2020
Completion date
May 31, 2022
Enrollment
9 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

catheterization, peripheral, peripheral arterial disease, peripheral vascular diseases